文献速递复苏、休克与脓毒症创伤与烧伤

微流控系统:创伤内皮病高通量评估及血浆输注时机对改善休克相关内皮功能障碍的作用

Microfluidics: A high-throughput system for the assessment of the endotheliopathy of trauma and the effect of timing of plasma administration on ameliorating shock-associated endothelial dysfunction.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论仿生微流控模型显示,休克后早期输注血浆可减轻糖萼降解和内皮促炎促血栓反应,延迟输注无保护作用,作者认为早期血浆输注对严重创伤患者可能有保护作用。

本研究将人脐静脉内皮细胞置于微流控流动通道中,过夜灌注后以肾上腺素处理并暴露于缺氧复氧,模拟创伤-失血性休克后内环境。分别于处理后立即(早期血浆)或延迟3小时(晚期血浆)灌注5%人血浆或单纯培养基,以荧光显微镜及syndecan 1、透明质酸脱落评估糖萼损伤,并检测可溶性血栓调节蛋白、组织型纤溶酶原激活物、纤溶酶原激活物抑制剂1及血管生成素1和2等内皮激活/损伤标志物,以ADAM金属肽酶结构域17评估脱落酶活性。结果显示微流控装置比静态条件更真实地模拟糖萼内皮血管屏障,模拟失血性休克内环境导致糖萼降解和内皮促炎促血栓反应,早期血浆灌注减轻这些效应,晚期血浆灌注无保护作用。作者认为该仿生模型观察到血浆输注的时间效应,提示早期血浆输注对严重创伤患者可能有保护作用。

要点

  • 微流控流动条件下培养的内皮细胞比静态条件更真实地模拟糖萼内皮血管屏障。
  • 模拟失血性休克内环境(肾上腺素+缺氧复氧)导致糖萼降解及内皮促炎促血栓反应。
  • 早期(处理后立即)灌注5%人血浆减轻糖萼降解和内皮激活/损伤,延迟3小时灌注无保护作用。
  • 作者认为该仿生模型提示早期血浆输注对严重创伤患者可能有保护作用。

适用人群与场景

  • 人脐静脉内皮细胞置于微流控流动通道中,模拟创伤-失血性休克后内皮血管屏障的体外模型。

处置流程与药物剂量

  • 内皮细胞在微流控流动通道中过夜灌注后,以肾上腺素处理并暴露于缺氧复氧。
  • 处理后立即灌注5%人血浆为早期血浆,延迟3小时灌注为晚期血浆。

研究设计与关键结果

  • 体外微流控模型研究:微流控装置比静态(无流动)条件下内皮细胞研究更真实地模拟糖萼内皮血管屏障。
  • 模拟失血性休克内环境导致糖萼降解和内皮促炎促血栓反应。
  • 早期血浆灌注减轻糖萼降解和内皮激活/损伤效应,晚期血浆灌注无保护作用。

证据类型、等级与局限

  • 证据类型:体外微流控模型研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该仿生模型观察到的血浆输注时间效应提示早期血浆输注对严重创伤患者可能有保护作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Early resuscitation after trauma-hemorrhagic shock with plasma rather than crystalloid may ameliorate systemic endothelial cell (EC) injury and dysfunction (endotheliopathy of trauma). We postulated that endothelial-lined microfluidic networks would be a useful platform to study the EC activation/injury under flow conditions to mimic trauma-hemorrhagic shock. We then used the microfluidic system to further characterize the protective effects and optimal timing of plasma infusion on the development of "endotheliopathy of trauma" in our model.

METHODS: Human umbilical vein ECs were added to microfluidic flow channels, and after overnight perfusion, the cells were subsequently treated with epinephrine and exposed to hypoxia reoxygenation. Media alone or 5% human plasma was perfused either immediately following treatment (early plasma) or after a 3-hour delay (late plasma). Glycocalyx injury was indexed by fluorescent microscopy and shedding of syndecan 1 and hyaluronic acid. Endothelial markers of activation/injury were also measured and included soluble thrombomodulin, tissue plasminogen activator, plasminogen activator inhibitor 1, and angiopoietins 1 and 2. Sheddase activity was indexed by ADAM metallopeptidase domain 17.

RESULTS: Endothelial cell and glycocalyx barrier function studies using microfluidic devices are a more realistic model of the glycocalyx endothelial vascular barrier than studies performed on ECs using static (no flow) conditions. Conditions that mimic the internal milieu following hemorrhagic shock result in glycocalyx degradation and an inflammatory prothrombotic response by the endothelium. "Early" use of plasma in the microfluidic channel perfusate mitigated against these effects. Later perfusion with plasma had no protective effect.

CONCLUSIONS: A temporal effect to plasma administration was noted in our biomimetic model of the endothelial vascular barrier following shock. This suggests a protective role to "early" plasma administration in the severely injured patient.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Diebel LN, Martin JV, Liberati DM, et al. Microfluidics: A high-throughput system for the assessment of the endotheliopathy of trauma and the effect of timing of plasma administration on ameliorating shock-associated endothelial dysfunction. J Trauma Acute Care Surg. 2018. PMID: 29287059. doi:10.1097/TA.0000000000001791

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。